Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers

Adv Drug Deliv Rev. 2018 Feb 1:125:1-2. doi: 10.1016/j.addr.2018.04.014.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Humans
  • Nanotechnology*
  • Neoplasms / diagnosis*
  • Neoplasms / metabolism
  • Neoplasms / pathology*
  • Neoplastic Cells, Circulating / pathology*
  • Prognosis

Substances

  • Biomarkers, Tumor